# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-213424
Filing Date
2026-05-08
Accepted
2026-05-08 08:30:42
Documents
74
Period of Report
2026-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | ck0002104204-20260331.htm iXBRL | 10-Q | 2891712
2 | EX-31.1 | ck0002104204-ex31_1.htm | EX-31.1 | 16715
3 | EX-31.2 | ck0002104204-ex31_2.htm | EX-31.2 | 16736
4 | EX-32.1 | ck0002104204-ex32_1.htm | EX-32.1 | 11005
5 | EX-32.2 | ck0002104204-ex32_2.htm | EX-32.2 | 11042
| Complete submission text file | 0001193125-26-213424.txt |  | 9896449

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | ck0002104204-20260331.xsd | EX-101.SCH | 1240845
78 | EXTRACTED XBRL INSTANCE DOCUMENT | ck0002104204-20260331_htm.xml | XML | 1619761

Mailing Address 47071 BAYSIDE PARKWAY FREMONT CA 94538
Business Address 47071 BAYSIDE PARKWAY FREMONT CA 94538 510-626-9888
Alamar Biosciences, Inc. (Filer) CIK: 0002104204 (see all company filings)

EIN.: 364899036 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-43235 | Film No.: 26956197
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)